ORYZA FDA Approval ANDA 213475

ANDA 213475

ORYZA

FDA Drug Application

Application #213475

Application Sponsors

ANDA 213475ORYZA

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 100MG BASE0DOXYCYCLINE HYCLATEDOXYCYCLINE HYCLATE

FDA Submissions

UNKNOWN; ORIG1AP2021-03-10STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

ORYZA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213475
            [companyName] => ORYZA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DOXYCYCLINE HYCLATE","activeIngredients":"DOXYCYCLINE HYCLATE","strength":"EQ 100MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/10\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-03-10
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.